NR566 Advanced Pharmacology for Care of the
Family Wk 2 Midterm v2 Questions with Correct
Answers and Expert Explanation for Each Question
1. A patient with a history of heart failure is prescribed a drug that has a high first-pass
effect. Which route of administration would be least effective for achieving systemic
circulation?
A. Intravenous
B. Sublingual
C. Transdermal
D. Oral
Correct Correct Answer: D
Expert Explanation: The first-pass effect occurs when a drug is metabolized by the
liver before it reaches the systemic circulation, which happens primarily with oral
administration. Because the drug is absorbed through the GI tract and carried via
the portal vein to the liver, a large portion is inactivated. Alternative routes such as
intravenous or sublingual bypass the liver’s initial metabolism, ensuring higher
bioavailability.
,2. Which pharmacokinetic process is primarily affected when two highly protein-
bound drugs are administered concurrently?
A. Absorption
B. Metabolism
C. Distribution
D. Excretion
Correct Correct Answer: C
Expert Explanation: Distribution is the process of moving a drug from the
bloodstream to the tissues, often involving binding to plasma proteins like albumin.
When two highly protein-bound drugs compete for the same binding sites, the
displacement of one drug increases its free, active concentration in the blood. This
can lead to increased pharmacological effects or toxicity even if the total dose
remains unchanged.
3. When prescribing a drug that is a known CYP450 enzyme inhibitor, the nurse
practitioner expects that a co-administered drug metabolized by that same enzyme
will:
A. Have a decreased half-life
B. Require an increased dosage
,C. Reach toxic levels more easily
D. Be excreted more rapidly
Correct Correct Answer: C
Expert Explanation: CYP450 inhibitors slow down the metabolic rate of substrate
drugs that rely on those specific enzymes for breakdown. As a result, the substrate
drug remains in the systemic circulation for a longer duration, leading to
accumulation. Clinicians must closely monitor for toxicity and potentially reduce the
dose of the substrate drug to maintain safety.
4. A 65-year-old patient is prescribed a new medication with a narrow therapeutic
index. What is the most important clinical consideration for this patient?
A. Small changes in dosage can lead to toxicity or subtherapeutic levels.
B. The drug is safe to use without monitoring blood levels.
C. The drug has a high margin of safety between therapeutic and toxic doses.
D. The patient will likely experience no side effects at all.
Correct Correct Answer: A
Expert Explanation: Drugs with a narrow therapeutic index (NTI) have a very slim
margin between the dose that is effective and the dose that is toxic. Precise dosing
and regular serum drug level monitoring are essential to ensure the patient stays
, within the therapeutic window. Even minor fluctuations in bioavailability or
metabolism can result in significant adverse clinical outcomes.
5. The nurse practitioner is considering a drug that acts as an agonist. How does this
drug exert its effect on the body?
A. By blocking the receptor and preventing activation
B. By irreversibly damaging the receptor site
C. By binding to a receptor and mimicking the endogenous ligand
D. By decreasing the affinity of the receptor for other drugs
Correct Correct Answer: C
Expert Explanation: An agonist is a drug that binds to a specific receptor and
activates it, producing a physiological response similar to the body’s natural
chemicals. This binding triggers a signal transduction pathway that leads to the
desired pharmacological effect. In contrast, an antagonist would bind to the receptor
to prevent such activation from occurring.
6. Which of the following describes the ‘steady state’ of a drug in the body?
A. When the rate of drug administration equals the rate of drug elimination
B. When the drug is completely eliminated from the body
C. When the drug reaches its peak concentration after the first dose
Family Wk 2 Midterm v2 Questions with Correct
Answers and Expert Explanation for Each Question
1. A patient with a history of heart failure is prescribed a drug that has a high first-pass
effect. Which route of administration would be least effective for achieving systemic
circulation?
A. Intravenous
B. Sublingual
C. Transdermal
D. Oral
Correct Correct Answer: D
Expert Explanation: The first-pass effect occurs when a drug is metabolized by the
liver before it reaches the systemic circulation, which happens primarily with oral
administration. Because the drug is absorbed through the GI tract and carried via
the portal vein to the liver, a large portion is inactivated. Alternative routes such as
intravenous or sublingual bypass the liver’s initial metabolism, ensuring higher
bioavailability.
,2. Which pharmacokinetic process is primarily affected when two highly protein-
bound drugs are administered concurrently?
A. Absorption
B. Metabolism
C. Distribution
D. Excretion
Correct Correct Answer: C
Expert Explanation: Distribution is the process of moving a drug from the
bloodstream to the tissues, often involving binding to plasma proteins like albumin.
When two highly protein-bound drugs compete for the same binding sites, the
displacement of one drug increases its free, active concentration in the blood. This
can lead to increased pharmacological effects or toxicity even if the total dose
remains unchanged.
3. When prescribing a drug that is a known CYP450 enzyme inhibitor, the nurse
practitioner expects that a co-administered drug metabolized by that same enzyme
will:
A. Have a decreased half-life
B. Require an increased dosage
,C. Reach toxic levels more easily
D. Be excreted more rapidly
Correct Correct Answer: C
Expert Explanation: CYP450 inhibitors slow down the metabolic rate of substrate
drugs that rely on those specific enzymes for breakdown. As a result, the substrate
drug remains in the systemic circulation for a longer duration, leading to
accumulation. Clinicians must closely monitor for toxicity and potentially reduce the
dose of the substrate drug to maintain safety.
4. A 65-year-old patient is prescribed a new medication with a narrow therapeutic
index. What is the most important clinical consideration for this patient?
A. Small changes in dosage can lead to toxicity or subtherapeutic levels.
B. The drug is safe to use without monitoring blood levels.
C. The drug has a high margin of safety between therapeutic and toxic doses.
D. The patient will likely experience no side effects at all.
Correct Correct Answer: A
Expert Explanation: Drugs with a narrow therapeutic index (NTI) have a very slim
margin between the dose that is effective and the dose that is toxic. Precise dosing
and regular serum drug level monitoring are essential to ensure the patient stays
, within the therapeutic window. Even minor fluctuations in bioavailability or
metabolism can result in significant adverse clinical outcomes.
5. The nurse practitioner is considering a drug that acts as an agonist. How does this
drug exert its effect on the body?
A. By blocking the receptor and preventing activation
B. By irreversibly damaging the receptor site
C. By binding to a receptor and mimicking the endogenous ligand
D. By decreasing the affinity of the receptor for other drugs
Correct Correct Answer: C
Expert Explanation: An agonist is a drug that binds to a specific receptor and
activates it, producing a physiological response similar to the body’s natural
chemicals. This binding triggers a signal transduction pathway that leads to the
desired pharmacological effect. In contrast, an antagonist would bind to the receptor
to prevent such activation from occurring.
6. Which of the following describes the ‘steady state’ of a drug in the body?
A. When the rate of drug administration equals the rate of drug elimination
B. When the drug is completely eliminated from the body
C. When the drug reaches its peak concentration after the first dose
